Target Therapies in Lung Cancer
Joint Authors
Berretta, Massimiliano
Bearz, A.
Tirelli, Umberto
Lleshi, A.
Source
Journal of Biomedicine and Biotechnology
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-03-30
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Targeting intracellular signaling molecules is an attractive approach for treatment of malignancies.
In particular lung cancer has reached a plateau regarding overall survival, and target therapies could offer the possibility to improve patients' outcome beyond cytotoxic activity.
The goal for target therapies is to identify agents that target tumor-specific molecules, thus sparing normal tissues; those molecules are called biomarkers, and their identification is recommended because it has a predictive value, for example, provides information on outcome with regard to a specific treatment.
The increased specificity should lead to decreased toxicity and better activity.
Herein we provide an update of the main target therapies in development or already available for the treatment of nonsmall cell lung cancer.
American Psychological Association (APA)
Bearz, A.& Berretta, Massimiliano& Lleshi, A.& Tirelli, Umberto. 2011. Target Therapies in Lung Cancer. Journal of Biomedicine and Biotechnology،Vol. 2011, no. 2011, pp.1-5.
https://search.emarefa.net/detail/BIM-508291
Modern Language Association (MLA)
Bearz, A.…[et al.]. Target Therapies in Lung Cancer. Journal of Biomedicine and Biotechnology No. 2011 (2011), pp.1-5.
https://search.emarefa.net/detail/BIM-508291
American Medical Association (AMA)
Bearz, A.& Berretta, Massimiliano& Lleshi, A.& Tirelli, Umberto. Target Therapies in Lung Cancer. Journal of Biomedicine and Biotechnology. 2011. Vol. 2011, no. 2011, pp.1-5.
https://search.emarefa.net/detail/BIM-508291
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-508291
